Anticoagulation after a VTE episode: when is it necessary, for how long and which drug to use

2018-06-15

Jeffrey Weitz

This lecture was recorded at the 3rd McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, please visit www.mircim.eu.

See also

Antithrombotic therapies: current patterns of practice and controversies A lecture by Dr Mark Crowther, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Popliteal vein thrombosis after a flight. Part 1 A 40-year-old otherwise healthy man had a popliteal vein thrombosis after a 9-hour flight. One month after the event there was no sign of a thrombus on ultrasonography and D-dimer levels were normal. What prophylaxis should be used in this patient before long-haul flights in the future?
Balancing the risk of recurrent VTE and the bleeding risk from anticoagulation How can we balance the risk of recurrent venous thromboembolism following an episode of unprovoked VTE and the increased bleeding risk associated with continued anticoagulation?
Recommended duration of dual antiplatelet therapy after stenting What is the currently recommended duration of dual antiplatelet treatment in patients after coronary artery stenting, carotid artery stenting, or peripheral artery stenting?
Hormonal contraceptives, routes of administration, and the risk of VTE Which hormonal contraceptives, routes of administration, and regimens are associated with the lowest risk of thrombosis?
Bariatric surgery in diabetes and obesity A lecture by Prof. Maria Tiboni, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2016.

Anticoagulation after a VTE episode: when is it necessary, for how long and which drug to use

Social Media